Can-Fite BioPharma Ltd. (CANF)
AMEX·Healthcare·Biotechnology
$3.08
+0.00%
Mkt Cap $2.20M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$7.25
Range $4.50 – $10.00
Implied Upside
+135.4%
Consensus $7.25 vs current $3.08
AMEX·Healthcare·Biotechnology
$3.08
+0.00%
Mkt Cap $2.20M
No recent rating data.
Price Target (2 analysts)
$7.25
Range $4.50 – $10.00
+135.4%
Consensus $7.25 vs current $3.08